Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Weiskirchen

Showing results (81-90 of 503) with videos related to

Pageof 51
Sort By:
Cytokine & Growth Factor Reviews|November 9, 2015
The PDGF system and its antagonists in liver fibrosisErawan Borkham-Kamphorst, Ralf Weiskirchen
Frontiers in Pharmacology|September 15, 2016
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic InjuryHans-Theo Schon, Ralf Weiskirchen
Methods in Molecular Medicine|August 25, 2005
Isolation and culture of hepatic stellate cellsRalf Weiskirchen, Axel M Gressner
Hepatology (Baltimore, Md.)|April 28, 2007
Bone morphogenetic protein-7 in focus: a member of the transforming growth factor-beta superfamily is implicated in the maintenance of liver healthRalf Weiskirchen, Steffen K Meurer
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1α, 25-dihydroxy-vitamin DJosef van Helden, Ralf Weiskirchen
Hepatology (Baltimore, Md.)|January 30, 2009
The genes that underlie fatty liver disease: the harvest has begunRalf Weiskirchen, Hermann E Wasmuth
Clinical Biochemistry|July 2, 2015
Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsiaJosef van Helden, Ralf Weiskirchen
Human Reproduction (Oxford, England)|June 22, 2015
Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assayJosef van Helden, Ralf Weiskirchen
Frontiers in Pharmacology|April 28, 2022
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021Ralf Weiskirchen, Angelo A Izzo
Journal of Hepatology|October 22, 2003
The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply?Axel M Gressner, Ralf Weiskirchen
Pageof 51

Showing results (81-90 of 503) with videos related to

Sort By:
Pageof 51
Cytokine & Growth Factor Reviews|November 9, 2015
The PDGF system and its antagonists in liver fibrosisErawan Borkham-Kamphorst, Ralf Weiskirchen
Frontiers in Pharmacology|September 15, 2016
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic InjuryHans-Theo Schon, Ralf Weiskirchen
Methods in Molecular Medicine|August 25, 2005
Isolation and culture of hepatic stellate cellsRalf Weiskirchen, Axel M Gressner
Hepatology (Baltimore, Md.)|April 28, 2007
Bone morphogenetic protein-7 in focus: a member of the transforming growth factor-beta superfamily is implicated in the maintenance of liver healthRalf Weiskirchen, Steffen K Meurer
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1α, 25-dihydroxy-vitamin DJosef van Helden, Ralf Weiskirchen
Hepatology (Baltimore, Md.)|January 30, 2009
The genes that underlie fatty liver disease: the harvest has begunRalf Weiskirchen, Hermann E Wasmuth
Clinical Biochemistry|July 2, 2015
Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsiaJosef van Helden, Ralf Weiskirchen
Human Reproduction (Oxford, England)|June 22, 2015
Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assayJosef van Helden, Ralf Weiskirchen
Frontiers in Pharmacology|April 28, 2022
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021Ralf Weiskirchen, Angelo A Izzo
Journal of Hepatology|October 22, 2003
The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply?Axel M Gressner, Ralf Weiskirchen
Pageof 51